29 jun: Shipping/Sydbank: Lave rater presser over hele linjen
29 jun: Obligationer/middag: Jubeloptimismen dæmpet en smule
29-06-2012 11:40:00

UPDATE: AB InBev to Buy Remaining Grupo Modelo Stake for $20.1 Billion

Relateret indhold

--AB InBev to pay $9.15 per share in cash

--Move would give AB InBev full control of Corona Extra brand

--Antitrust regulators' approval remains question mark

(Rewrites throughout, adds analyst comment in seventh paragraph.)

BRUSSELS--Anheuser-Busch InBev NV (ABI.BT) said Friday it is acquiring the stake it doesn't yet own in Mexican brewer Grupo Modelo SAB (GMODELO.MX) in a deal worth $20.1 billion that would give the Belgian company full control of Corona Extra, one of the world's top beer brands, and cement its position in the growing South American market.

In a joint statement, the companies said the merger will be "completed through a series of steps that will simplify Grupo Modelo's corporate structure, followed by an all-cash tender offer by AB InBev for all outstanding Grupo Modelo shares."

They said the tender price for the shares -- AB InBev is offering $9.15 per share in cash -- represents a premium of around 30% to Grupo Modelo's closing price on June 22.

AB InBev already owns a non-controlling 50% stake in Grupo Modelo and the combined company would "lead the global beer industry" with estimated 2012 revenues of $47 billion from operations in 24 countries, the companies said.

The Modelo sale to AB InBev ends a contentious history between the companies. AB InBev won its 50% Modelo stake through InBev's $52 billion acquisition in 2008 of Budweiser producer Anheuser-Busch, a deal that created the world's largest beer maker by sales. Anheuser had tried unsuccessfully to entice Modelo to merge with the U.S. brewing giant after it received the unsolicited approach from InBev, people familiar with the matter said at the time.

Approval of the deal by antitrust regulators remains a question mark, as AB InBev has considerable market power in the U.S. and elsewhere. Modelo has some strong brands, especially Corona.

"The combination of both breweries creates a pan-American powerhouse with number one or two positions in every major market from Canada to Argentina," said Marc Leemans, an analyst at Bank Degroof in Brussels.

The move will increase competitive pressure in Mexico and create a stronger rival for Heineken NV (HEIA.AE) there, SNS Securities added. The broker said Grupo Modelo has a market share of around 56% in Mexico, while Heineken holds roughly 41% through its Femsa unit. Competition will likely heat up as soon as AB Inbev realizes synergies from its tie-up with Grupo Modelo, SNS said.

The two companies said they believed the cost savings from the merger would be worth at least $600 million annually.

"There is tremendous opportunity from combining two leading brand portfolios and further expanding Grupo Modelo's brands worldwide through AB InBev's extensive global distribution network," said Carlos Brito, Chief Executive of Anheuser-Busch InBev.

The companies said Grupo Modelo would keep its name and identity, would continue to be headquartered in Mexico City and would keep its local board.

--Amy Guthrie in Mexico City and Alessandro Torello in Brussels contributed to this article.

Write to Laurence Norman at Laurence.norman@dowjones.com

(END) Dow Jones Newswires

June 29, 2012 05:40 ET (09:40 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo/ATP: Succes afhænger også af de mindste forretningsben

23-03-2017 15:28:28
Hvis Novo Nordisk skal forblive succesfuld i den kommende årti, så er det ikke nok, at Novo styrker sin førerposition på diabetesmarkedet. Novos forretning inden for fedme og hæmofili må også styrkes, mener ATP, der derfor benyttede taletiden på generalforsamlingen til at spørge ind til Novos syn på opkøb.- Efter min mening er det nødvendigt, at Novo Nordisk supplerer sin interne forskning og udvi..

Novo/CEO: Vi skal stadig fokusere på produktfornyelse

23-03-2017 14:34:32
Novo Nordisk har stærke produkter, men står samtidig over for store udfordringer i USA, hvor sygekasserne presser på for at sænke priserne.Det erkender administrerende direktør Lars Fruergaard Jørgensen på torsdagens generalforsamling.- På den ene side har Novo Nordisk med en meget stærk produktportefølje, men på den anden side står vi også over for et meget stærkt pres på vores forretning i USA, ..

Aktier/åbning: Mærsk skyder til tops i C20 efter Nordsøaftale

23-03-2017 09:18:19
Investorerne er glade for A.P. Møller-Mærsk-aktierne torsdag morgen, hvor det er gjort klart, at Thyra-feltet vil blive genopbygget efter en aftale om olie- og gasproduktion i Nordsøen.Mærsks A-aktie stiger med 0,5 pct. til 11.120 kr., og B-aktien stiger med 0,3 pct. til 11.540 kr.- Det er ret væsentligt for Maersk Oil, at det her kommer i hus, for ambitionen om selvstændighed og om at fokusere si..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo/aktionærer: Tingene kører ikke længere af sig selv
2
Pandora vil uddele optioner for op til 77 mio. kr.
3
Parken får bøde og Don Ø idømmes fængsel i halvandet år - NY2
4
Novo/ATP: Succes afhænger også af de mindste forretningsben
5
Torsdagens aktier: Vestas, Lundbeck og Pandora i pæn form i grønt C20

Relaterede aktiekurser

Anheuser-Busch Inbev SA .. 110,98 0,0% Aktiekurs uændret
Heineken 78,97 0,0% Aktiekurs uændret
AB Inbev 103,20 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. marts 2017 09:09:22
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170322.1 - EUROWEB5 - 2017-03-24 09:09:22 - 2017-03-24 09:09:22 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x